US Stock MarketDetailed Quotes

IPHA Innate Pharma

Watchlist
  • 2.380
  • -0.080-3.25%
Trading Apr 29 13:10 ET
192.40MMarket Cap-24791P/E (TTM)

Innate Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Innate Pharma Earnings Date

Currency: EUR

Period

FY2023 Annual Report

Mar 21, 2024

Revenue(YoY)

51.90M

+4.68%
EPS(YoY)

-0.09

+87.67%
Analyst Rating

Buy

Apr 16, 2024

Innate Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 10, 20202019/Q413.330M / 22.402M--
--2019/Q313.330M / 24.747M--
Sep 13, 20192019/Q229.580M / 43.206M--
--2019/Q1-- / 43.206M--
DatePeriodRevenue/EstimateEarnings Call
Mar 10, 20202019/Q413.330M / 22.402M--
--2019/Q313.330M / 24.747M--
Sep 13, 20192019/Q229.580M / 43.206M--
--2019/Q1-- / 43.206M--

Innate Pharma Earnings Reports

  • Innate Pharma | 20-F: Registration statement / Annual report / Transition report

    Apr 4 08:10 ET

  • Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 21 09:26 ET

  • Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 21 06:06 ET

  • Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 14 07:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 16, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg